OF SPECIAL INTEREST
More information emerging on NSAIDs' potential cardiovascular risks
ICU infection-prevention efforts could be better, study finds
Stakeholders discuss biosimilar naming, substitution
News Briefs
Tips for a successful poster presentation
Ruxolitinib for the treatment of primary myelofibrosis
Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis
Cost-minimization analysis of two fluid products for resuscitation of critically injured trauma patients
Aseptic simulation test for cytotoxic drug production in isolators
National trends in prescription drug expenditures and projections for 2014
Evidence to support use of palonosetron over generic serotonin type 3–receptor antagonists for chemotherapy-induced nausea and vomiting
Serotonin type 3–receptor antagonists for chemotherapy-induced nausea and vomiting